Furthermore, we explored the correlation of TGFBI/TAGLN expression with stem cell markers (NANOG, POU5F1, SOX2, ALDH1, and BCL11B) and EMT markers (S100A4 and VIM) in HNSCC cells. The gene discussed is SOX2; the disease is head and neck squamous cell carcinoma.